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Abstract
Background
Women have a greater risk of heart failure with preserved ejection fraction (HFPEF) than
men do, yet the basis for this disparity remains unclear. Greater arterial stiffness and after-
load causes left ventricular (LV) diastolic dysfunction, a central mechanism of HFPEF.
Because of smaller body habitus, previous reports have used body surface area as a surro-
gate of the size of the aorta. We performed a comprehensive hemodynamic evaluation of
elderly patients with preserved EF and evaluated sex differences in the associations
between LV function and afterload, before and after adjusting for the aortic sizes.
Methods and results
Four hundred and forty-three patients (mean age: 73 years, 169 women) who underwent
clinically indicated echocardiography and computed tomography (CT) were identified. Lin-
ear regression analyses were performed to assess the independent contributions of sex to
and its interaction with LV function before and after adjusting for CT-derived aortic length
and volume. Although blood pressures were similar between the sexes, women had greater
arterial elastance, lower arterial compliance, and greater LV ejection fraction (all p<0.001).
Sex differences were detected in the associations between LV afterload and relaxation
(mitral e0) as well as in the left atrial (LA) emptying fraction, but not in LA size. These differ-
ences remained significant after adjusting for the aortic length and volume. Sensitivity analy-
ses in an age-matched subgroup (n = 324; 162 of each sex) confirmed the robustness of
these sex disparities in LV diastolic function and afterload.
Conclusion
Women had worse LV relaxation than men did against the same degree of afterload, before
and even after adjusting for the aortic sizes.
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Introduction
Heart failure (HF) is a major clinical and public health problem owing to its high prevalence,
mortality, hospitalization, and healthcare expenditures.[1] Relative prevalence of HF with pre-
served ejection fraction (HFPEF) to HF with reduced EF (HFREF) is rising over time; yet the
survival in HFPEF has remained dismal due to the lack of proven therapies. Several large clini-
cal trials for HFPEF have demonstrated neutral results.[2–4] Further elucidation of the mecha-
nisms underlying HFPEF may aid in identifying a novel therapeutic target.
Women have an approximately two-fold increased risk of developing HFPEF compared to
men[5] but little is known about the precise mechanisms for this increase. Although the preva-
lence of HFPEF is higher in women than in men at any given age, the prevalence of HFPEF
increases more rapidly with age than did the prevalence of HFREF[6]. Therefore, elderly women
have a greater risk of HFPEF. Arterial stiffness augments central aortic pressure wave and
increases left ventricular (LV) afterload, and thus may promote impaired diastolic function. Pre-
vious studies have shown that independent interaction of sex on the associations between after-
load and diastolic functional responses after adjusting for body surface area (BSA), based on the
assumption that BSA is a reasonable surrogate for the aorta size.[7, 8] Since the aorta serves both
as a conduit for delivering blood to peripheral organs and as a cushion for buffering the pulsatile
pressure and flow from the heart, directly measured aortic length and volume would serve as
more accurate physiological indices, but there are few studies that have used such a detailed
examination. We hypothesized that the sex difference in the relationships between left ventricu-
lar afterload and diastolic function would be independent from the differences in aorta size.
Accordingly, the aims of this study were to confirm the sex difference in the associations between
LV (systolic and diastolic) functions and afterload in our population, and then to elucidate
whether these differences remain significant after adjusting for the aortic length and volume.
Materials and methods
Subjects
In this retrospective, cross-sectional study, all patients who had undergone clinically indicated
echocardiography and computed tomography (CT) within a 12-month period were screened for
eligibility. Of 848 patients who had echocardiography and CT from October 2012 to July 2014 at
Maebashi Red Cross Hospital, Gunma, Japan, 405 were excluded for the following reasons:
reduced LVEF (<45%) (n = 79), atrial fibrillation (n = 122), greater than mild mitral valvular
heart disease (n = 28), greater than mild aortic valvular heart diseases (n = 34), LV asynergy
(n = 41), heart failure (n = 47), chronic renal failure on hemodialysis (n = 53) and poor echocar-
diographic image quality (n = 1), leaving 443 participants for the final analyses. Their clinical
indications for echocardiography were: to assess cardiac function (n = 372), to rule out infective
endocarditis (n = 27) or intracardiac thrombosis (n = 29), and to assess valvular disease (= 15).
The clinical indications for CT were to assess thoracic disease (n = 114), abdominal disease
(n = 156), vessel disease(n = 34), hematologic disease(n = 10), fever of unknown origin(n = 36),
pulmonary embolism or deep venous thrombosis(n = 16) and others(n = 77).
We also performed sensitivity analyses using 324 age-matched subjects (162 men and 162
women), in which each consecutive female subject was matched to a male participant of the
same age (1:1). If an exact age match could not be found, the male subject closest in age to the
female subject’s (within a 5-year difference) was selected.
The institutional medical ethics committee of the Maebashi Red Cross Hospital approved
the study protocol with a waiver of the requirement to obtain informed consent (IRB number:
26–25).
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Two-dimensional and Doppler echocardiography
Two-dimensional echocardiography was performed using a commercially available ultrasound
system (Vivid E9, GE healthcare, Milwaukee, Wisconsin). Standard two-dimensional mea-
surements, including of systolic and diastolic functions, were obtained as recommended by
the American Society of Echocardiography.[9, 10] Mitral inflow velocities were recorded, and
the following variables were obtained: peak velocity of early diastolic mitral inflow (E), late dia-
stolic mitral inflow (A), and the deceleration time of the E velocity. Mitral annular velocities
were measured with spectral Doppler. Early diastolic mitral annular (e0), late diastolic (a0) and
systolic velocities (s0) of the mitral annulus were measured from the apical 4-chamber view
with a 2- to 5-mm sample volume placed at the septal and lateral corners of the mitral annulus,
then averaged. The E/e0 ratio was used to estimate the LV filling pressure. Left atrial volumes
(LAVs) were measured using the area-length method from the 4- and 2-chamber views and
subsequently indexed (LAVI) by BSA.[11] LA emptying fraction was defined as (end-systolic
LAV–end-diastolic LAV) / end-systolic LAV × 100.[12]
Measurement of hemodynamics
The following hemodynamic parameters were estimated non-invasively. Mean arterial pres-
sure was calculated using systolic (SBP) and diastolic blood pressures (DBP), as [(2 × DBP)
+ SBP] / 3. Brachial pulse pressure (PP) was calculated as brachial SBP–DBP. Total afterload
was defined by the arterial elastance (Ea) (0.9 × systolic BP / SV).[13–15] The systemic vascular
resistance index (SVRI), the non-pulsatile component of afterload,[16] was determined by
dividing the mean BP / cardiac index × 79.9.[17] Total arterial compliance (TAC) was esti-
mated by the ratio of SV to PP,[18] which is the change in arterial blood volume due to a given
change in pulsatile arterial blood pressure.[19] Brachial-ankle pulse wave velocity (baPWV)
data, using commercially available brachial artery tonometry (Omron Colin Co., Tokyo,
Japan), was available in a subgroup of 100 patients and used as a parameter of arterial stiffness.
The measurements were obtained in the supine position after a minimum of 5 minutes of rest.
Measurement of aortic length and volume
Patients underwent imaging using standard commercially available CT scanners (Aquilion
64-slice; TOSHIBA or SIEMENS SOMATOM Definition Flash 128-slice; Siemens Medical
Solution or SIEMENSE SOMATOM Emotion 16-slice; Siemens Medical Solution). Scanning
from the neck to the pelvis was initiated in the cranio-caudal direction during a single inspira-
tory breath hold. Prospectively triggered axial or retrospectively gated spiral data were
acquired. The tube voltage ranged from 120 to 130 kVp; tube current was adjusted by patient
weight; and a beam pitch of 0.8 was used.[20–22]
Subsequently, with commercially available software (Zaiostation2, Ziosoft, Tokyo, Japan),
advanced offline 3-dimensional post-processing of CT images was performed using multi-pla-
nar and maximum intensity projections. Aortic length was measured by manually plotting the
center of the vessel lumen from the ST junction to the aortic bifurcation (Fig 1A). Then, aortic
volume was assessed by tracing the aortic intramembrane border on about 20 slices from the
ST junction to the aortic bifurcation on axial-plane images and calculating the volume using
reconstructed three-dimensional data (Fig 1B).
Reproducibility of aortic length and volume
The reproducibility of the aortic length and volume measurement was assessed in 20 randomly
selected patients. Intra-observer agreement was evaluated after the same observer (H.S.)
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repeated the measurements 4 weeks later, and inter-observer agreement was tested by compar-
ing the measurement made by another experienced reader (M.N.). The intraclass correlation
coefficients for intra-observer and inter-observer agreement for aortic length were 0.94 and
0.89. The intraclass correlation coefficients for intra-observer and inter-observer agreement
for aortic volume were 0.99 and 0.98. The coefficient of variations for aortic length were 1.4%
(for intra-observer) and 2.3% (for inter-observer), while those for aortic volume were 2.4%
and 3.2%, respectively.
Statistical analysis
All continuous variables are presented as mean ± standard deviation (SD) or median (25th and
75th percentile), as appropriate. Categorical variables are presented as absolute and relative
frequencies (%). Normality was evaluated using the Shapiro-Wilk W test. e0, E/e0, and LAVI
were log-transformed when put into the models based on their distributions. Differences
between sexes were compared by the Student t test, the χ2 test, or the Mann-Whitney U-test,
as appropriate.
To determine the associations of the indices of afterload/arteriosclerosis (SBP, mean BP,
PP, Ea, SVRI, arterial compliance, aortic calcification, LV mass index, and baPWV) with LV
function (log-transformed e0 velocity, E/e0, LAEF, LAVI, LVEF, and s’) for each sex, sex-spe-
cific single linear regression analyses were performed. Multivariable linear regression analyses
were performed to assess the independent contributions of sex to LV functions. Then, linear
regression models with an interaction term were performed to determine the effect of sex dif-
ferences on the associations between afterload and LV functions or anatomy. Homoscedastic-
ity of the errors and normality of the error distributions were checked in residual plots. We
assessed whether there was a sex interaction in the relationship between afterload and LV func-
tion before and after adjusting for aortic size (aortic length and volume). A two-sided p value
of<0.05 was considered statistically significant. All data were analyzed using SPSS version
21.0 (SPSS Inc., Chicago, IL, USA).
Fig 1. Measurement of the aortic length and volume with computed tomography. (A)The aortic length is measured by plotting the center of the vessel
lumen from the ST junction to the aortic bifurcation. (B) The aortic volume is measured by tracing the arterial intima (in green) on about 20 slices from the ST
junction to the aortic bifurcation on an axial-plane image, and then the volume is calculated using reconstructed data.
https://doi.org/10.1371/journal.pone.0214907.g001
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Results
Patient characteristics
Baseline characteristics by sex for the whole population and the age-matched population are
summarized in Table 1. In the whole population, women tended to be older, but not signifi-
cantly (74 vs 72, p = 0.062). All physical parameters were significantly smaller in women than
Table 1. Clinical characteristics of WHOLE sample and AGE-MATCED sample.
WHOLE sample(n = 443) AGE-MARCHED sample(n = 324)
Overall
(n = 443)
Male
(n = 274)
Female
(n = 169)
p value Male
(n = 162)
Female
(n = 162)
p value
Age, years 73(65, 81) 72(65, 80) 74(66, 83) 0.062 74(67, 82) 74(66, 82) 0.58
Height, cm 159±10 164±7 151±7 <0.001 163±7 151±7 <0.001
Weight, kg 57±13 61±12 50±10 <0.001 59(52, 67) 49(44, 56) <0.001
Body surface area, m2 1.6±02 1.7±0.2 1.4±0.2 <0.001 1.64(1.54, 1.74) 1.43(1.34, 1.55) <0.001
Body mass index, kg/m2 22.4±3.8 22.7±3.9 22.0±3.7 0.081 22.4(19.8,24.7) 21.9(1.94, 24.8) 0.48
Comorbidities
Hypertension 239(54) 150(54) 89(53) 0.67 95(58) 86(53) 0.29
Diabetes mellitus 109(25) 80(29) 29(17) 0.004 49(30) 29(17) 0.009
Dyslipidemia 112(25) 78(29) 34(20) 0.050 48(29) 34(21) 0.074
Ischemic heart disease 71(17) 55(20) 16(10) 0.003 31(19) 16(10) 0.020
Smoking 207(47) 177(65) 30(18) <0.001 105(65) 30(18) <0.001
Hb, mg/dl 12.3±2.3 12.7±2.4 11.8(10.4,13.0) <0.001 12.3±2.4 12.0±1.9 0.004
Creatinine, mg/dl 0.78(0.64,1.01) 0.89(0.73,1.13) 0.68(0.55,0.96) <0.001 0.91(0.74, 1.18) 0.68(0.55, 0.86) <0.001
eGFR, mL/min/1.73 m2 68.0±25.5 67.3±24.7 69.3±26.9 0.43 65.0±24.6 68.9±25.3 0.19
BNP, pg/ml† 49.2(21.7, 136.7) 39.6(18.8, 116.8) 72.5(31.2, 196.5) 0.008 48.4(22.4,136.0) 70.0(31.2, 200.2) 0.14
Medications
Aspirin 67(15) 47(17) 20(12) 0.13 23(15) 18(11) 0.41
Clopidegrel 56(13) 39(14) 17(10) 0.20 29(18) 17(11) 0.062
Ca-blocker 144(32) 89(33) 55(32) 0.89 40(25) 51(32) 0.58
Beta-blockers 64(15) 43(16) 21(13) 0.36 23(14) 22(14) 0.82
ACEIs/ARBs 104(24) 63(23) 41(24) 0.78 39(24) 38(23) 0.86
Diuretics 46(10) 30(11) 16(10) 0.61 21(13) 12(8) 0.13
Statins 84(19) 59(22) 25(15) 0.073 34(21) 25(15) 0.20
Hemodynamic Parameters
Heart rate, beats/min. 71(61, 81) 70(60, 79) 73(64, 82) 0.039 70(60, 79) 73(64, 83) 0.044
Systolic BP, mmHg 128(114, 141) 128(113, 140) 129(114, 144) 0.28 128(113, 141) 130(115,146) 0.20
Diastolic BP, mmHg 72(63, 83) 72(63, 83) 72(63, 83) 0.93 71(61, 82) 73(63, 84) 0.14
mean BP, mmHg 90(81, 103) 90(81, 103) 91(81, 102) 0.78 89(79, 102) 92(81, 103) 0.20
Pulse pressure, mmHg 54(45, 64) 53(44, 63) 55(46, 66) 0.18 55(45, 64) 55(46, 66) 0.79
Ea, mmHg/ml 2.6(2.1, 3.1) 2.3(1.9, 2.9) 3.0(2.5, 3.6) <0.001 2.4(1.9, 2.9) 3.0(2.5, 3.7) <0.001
SVRI, dyne�m2/s�cm-5 3580(2924, 4611) 3562(2867, 4509) 3597(3020, 4706) 0.50 3497(2819, 4452) 3642(3037, 4841) 0.17
Arterial compliance, ml/ mmHg 0.83(0.65, 1.08) 0.93(0.74, 1.17) 0.70(0.55, 0.87) <0.001 0.91(0.73, 1.15) 0.70(0.56, 0.89) <0.001
baPWV, cm/sec⁑ 1796(1589, 2097) 1777(1536, 2037) 1872(1648, 2142) 0.26 1791(1537, 2001) 1880(1669, 2192) 0.18
Values are mean ± SD, median (interquartile range), or n (%). Hb, hemoglobin; eGFR, estimated glomerular filtration rate. BNP, brain natriuretic peptide; ACEIs/ARBs,
angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers; BP, blood pressure; Ea, aortic elastance; SVR, systemic vascular resistance; SVRI, systemic
vascular resistance index, baPWV; brachial ankle pulse wave velocity.
†In whole population, BNP was measured in 227 cases (139 in men,88 in women).In age matched population, 165 cases(85 in men,80 in women)
⁑In whole population, baPWV was measured in 69 cases (44 in men, in 25 women). In age matched population, 49 cases(25 in men,24 in women)
https://doi.org/10.1371/journal.pone.0214907.t001
Sex differences in cardiac function and afterload
PLOS ONE | https://doi.org/10.1371/journal.pone.0214907 April 4, 2019 5 / 18
in men except for body mass index. Diabetes mellitus and ischemic heart disease were more
common in men. Although the serum creatinine level was higher in men, both sexes shared a
similar estimated glomerular filtration rate. Approximately a half of them (n = 227) had BNP
levels, where women had higher BNP than men. No differences were found in their medica-
tion use. Among the hemodynamic parameters, heart rate was higher in women than in men,
although the systolic, diastolic, and mean BPs, PP, and SVRI were similar. Women had higher
Ea and lower TAC than men did. These differences were also observed in the age-matched
population, except for BNP level, which was similar between the sexes.
Findings from cardiovascular imaging modalities
Table 2 summarizes findings from echocardiography and CT. Even after indexing to BSA,
female patients had smaller LV sizes and stroke volume indices than male patients did. LVEFs
were within the normal ranges but higher in women than in men. With respect to diastolic
function, women had higher E/e0 ratios, slower e0s, and smaller LAEFs. The aortic length was
shorter in women than in men (45.4 ± 3.4 cm vs. 49.7 ± 3.5, p<0.001). Aortic volume was
smaller in women than in men (167 ± 43 ml vs. 219 ± 56 ml, p<0.001). Findings from the age-
matched population were consistent with these findings. Aorta length and BSA had weak
Table 2. Findings from cardiovascular imaging modalities (echocardiography and CT).
WHOLE sample(n = 443) AGE-MATCHED sample(n = 324)
Overall
(n = 443)
Men
(n = 274)
Women
(n = 169)
p value Men
(n = 180)
Women
(n = 180)
p value
Echocardiographic Findings
Septal wall thickness, mm 9.5±2.1 9.7±2.1 9.0(7.9, 10.6) 0.022 10.0±2.4 9.3±2.0 0.009
Posterior wall thickness, mm 9.4±1.5 9.6±1.4 9.1(8.1, 10.2) <0.001 9.8±2.3 9.1±1.5 0.002
LV mass index, g/m2 86.2(71.3, 102.5) 89.3 84.9 0.22 86.8(74.5, 102.0) 83.8(68.9, 100.3) 0.20
LV end-diastolic volume index, ml/ m2 44.8(38.2, 54.8) 47.8(39.7, 56.7) 41.6(36.5, 49.6) <0.001 48.4(39.8, 57.2) 41.5(36.3, 49.2) <0.001
LV end-systolic volume index, ml/ m2 16.6(12.9, 21.5) 17.8(14.1, 22.3) 14.3(11.3, 18.7) <0.001 17.4(14.1, 22.4) 14.3(11.3, 18.6) <0.001
LVEF, % 63.4±6.4 62.5±6.6 64.8±5.8 <0.001 62.5±6.6 64.6±5.7 0.002
Stroke volume index, ml/ m2 28.5(24.2, 34.0) 29.3(24.9, 34.6) 27.2(23.3, 31.8) 0.008 29.6(24.9, 35.4) 27.0(23.0, 31.5) 0.007
E velocity, cm/sec 60.2(51.2, 71.0) 58.6(50.7, 69.6) 62.3(52.8, 73.8) 0.049 60.2(50.3, 71.1) 62.3(52.2, 72.2) 0.33
A velocity, cm/sec 81.9±22.1 78.6±21.1 87.4±22.6 <0.001 79.6±20.4 87.2±21.5 0.001
E/A ratio 0.75(0.62, 0.90) 0.76(0.64, 0.90) 0.72(0.60, 0.91) 0.12 0.72(0.62, 0.92) 0.72(0.60, 0.90) 0.19
Deceleration time, msec 246±68 246±67 246±70 0.95 247±74 246±69 0.87
e’(average), cm/sec 6.4(5.3, 7.9) 6.6(5.5, 8.2) 6.1(4.9, 7.7) 0.004 6.5(5.2, 7.9) 6.1(4.9, 7.7) 0.10
a’(average), cm/sec 9.6±2.1 9.7±2.0 9.3±2.1 0.045 9.5±2.1 9.4±2.1 0.75
s’(average), cm/sec 7.6±2.0 7.8±2.1 7.2±1.8 0.001 7.7±2.0 7.3±1.7 0.034
E/e’(average) 9.1(7.3, 11.8) 8.8(7.0, 11.2) 9.8(7.8, 12.8) <0.001 9.3(7.1, 11.5) 9.7(7.8, 12.6) 0.033
LAVI max, mL/m2 28.0(22.1, 36.9) 27.2(21.5, 35.4) 28.6(22.5, 38.6) 0.082 28.8(21.9, 36.5) 28.4(22.5, 37.5) 0.63
LAVI min, mL/ m2 12.0(8.1, 17.1) 11.7(7.5, 16.3) 13.1(9.5, 19.5) 0.002 11.9(7.5, 16.5) 12.8(9.6, 19.4) 0.020
LAEF, % 57.2(48.1, 65.9) 58.8(49.4, 68.3) 55.5(46.4, 61.5) <0.001 60.6(48.8, 68.9) 55.6(46.5, 61.7) <0.001
CT parameters
Aorta length, cm 48.1±4.1 49.7±3.5 45.4±3.4 <0.001 49.7±3.5 45.5±3.4 <0.001
Volume of aorta, ml 199±58 219±56 167±43 <0.001 222±59 167±43 <0.001
Values are mean ± SD or median (interquartile range). E, early mitral diastolic inflow velocity; e’, early diastolic mitral annular velocity; LAEF, left atrial emptying
fraction; LAVI max, maximum left atrial volume index; LAVI min, minimum left atrial volume index; LV, left ventricular; LVEF, left ventricular ejection fraction; a’,
end diastolic velocity of the mitral annulus; s’, systolic mitral annular velocity.
https://doi.org/10.1371/journal.pone.0214907.t002
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associations in both sex (women: r = 0.18, p = 0.021, men: r = 0.21, p<0.001), as well as aorta
volume did (women: r = 0.11, p = 0.053, men: r = 0.22, p<0.001) (Fig 2).
Sex differences in the associations between afterload parameters and
cardiac functions
Sex-specific associations between the afterload markers and cardiac anatomy or mechanics in
the whole population are summarized in Table 3. Significant sex differences were confirmed in
the associations between e0 and the indices of afterload, except for Ea (Fig 3), where women
had lower e’ than men to the similar level of afterload. These differences remained significant
after adjusting for aortic length and volume except for SVRI. Significant interactions were also
noted between E/e’ and systolic or mean BP, even after adjusting for the aortic length or vol-
ume. Among LA parameters, interactions were observed between LA function (i.e. LAEF) and
BPs but not between LA volume and afterload markers. Intriguingly, significant associations
between LV systolic function (i.e. LVEF) and several afterload parameters (diastolic BP, mean
BP, Ea, SVRI, and TAC) were seen only in men but none in women. Then, sex differences
were seen in the relationships between LVEF and Ea or SVRI, which remained significant after
adjusting for the aortic sizes. Collectively, LV diastolic function and afterload parameters had
stronger association in women than men even after adjusting for the aorta sizes. Whereas men
had stronger association between LV systolic function and afterload than women, regardless of
adjusting for the aortic sizes or not.
The results from the sensitivity analyses in the age-matched population are reported in
Table 4 and Fig 4. In general, findings from this subgroup corroborated above findings from
the whole population. Sex differences observed in the age-matched cohort were in the associa-
tions between e0 and BPs (p<0.05 for BPs with borderline significance in pulse pressure,
p = 0.051 ~ 0.053), but not with SVRI and TAC, irrespective of adjustment for the aortic sizes.
Of note, the independent sex difference between E/e0 and diastolic BP after adjusting for the
Fig 2. Association of aorta size and body surface area (BSA). The association with aorta length and BSA is illustrated in panel A, that with aorta volume and
BSA in panel B. There were significant but weak associations between BSA and aortic sizes.
https://doi.org/10.1371/journal.pone.0214907.g002
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Table 3. Sex specific linear regression analysis and sex differences in associations between afterload and cardiac function in WHOLE sample.
Univariable linear regression models Models with interaction for sex difference
Men (n = 307) Women (n = 189) Interaction Interaction
Adjusted for
Aorta length
Interaction
Adjusted for
Aorta volume
β(95% CI) p value β(95% CI) p value β p-value β p-value β p-value
Ln e’(average), cm/sec
systolic BP, mmHg -0.002(-0.004, -0.001) 0.011 -0.006(-0.009, -0.004) <0.001 -0.004 0.003 -0.004 0.005 -0.004 0.023
diastolic BP, mmHg -0.002(-0.005, 0.001) 0.12 -0.008(-0.011, -0.004) <0.001 -0.006 0.007 -0.005 0.013 -0.006 0.008
mean BP, mmHg -0.003(-0.005, 0.000) 0.021 -0.009(-0.012, -0.005) <0.001 -0.006 0.003 -0.005 0.006 -0.006 0.004
Pulse pressure, mmHg -0.003(-0.005, 0.000) 0.035 -0.007(-0.010, -0.004) <0.001 -0.004 0.041 -0.004 0.050 -0.004 0.035
Ea, mmHg/ml -0.11(-0.149, -0.060) <0.001 -0.15(-0.199, -0.105) <0.001 -0.047 0.15 -0.041 0.20 -0.042 0.18
SVRI, dyne�m2/s�cm-5 -0.006(-0.008,0.003) <0.001 -0.010(-0.014, -0.006) <0.001 -0.005 0.043 -0.004 0.070 -0.004 0.059
TAC, ml/mmHg 0.26(0.154, 0.357) <0.001 0.48(0.313, 0.642) <0.001 0.22 0.021 0.21 0.023 0.21 0.023
LVMI, g/ m2 -0.002(-0.004, 0.000) 0.013 -0.004(-0.006, -0.002) <0.001 -0.002 0.15 -0.001 0.33 -0.002 0.18
Ln baPWV, cm/sec⁑ -0.44(-0.912, 0.027) 0.064 -0.74(-1.384, -0.087) 0.028 -0.29 0.44 -0.11 0.77 -0.21 0.81
Ln E/e’(average)
systolic BP, mmHg 0.002(0.000, 0.004) 0.068 0.005(0.003, 0.008) <0.001 0.003 0.038 0.003 0.043 0.003 0.041
diastolic BP, mmHg -0.001(-0.004, 0.002) 0.44 0.003(-0.001, 0.007) 0.16 0.004 0.10 0.004 0.12 0.004 0.11
mean BP, mmHg 0.001(-0.002, 0.003) 0.45 0.006(0.002, 0.009) 0.004 0.005 0.029 0.005 0.034 0.005 0.032
Pulse pressure, mmHg 0.005(0.002, 0.008) 0.001 0.008(0.004, 0.012) <0.001 0.003 0.16 0.003 0.16 0.004 0.13
Ea, mmHg/ml 0.027(-0.026, 0.079) 0.32 0.082(0.023, 0.140) 0.006 0.055 0.16 0.052 0.18 0.053 0.17
SVRI, dyne�m2/s�cm-5 0.001(-0.002, 0.004) 0.51 0.004(0.001, 0.009) 0.004 0.003 0.33 0.002 0.41 0.003 0.36
TAC, ml/mmHg -0.14(-0.257, -0.019) 0.023 -0.33(-0.531, -0.130) 0.001 -0.19 0.098 0.19 0.10 -0.19 0.10
LVMI, g/ m2 0.003(0.001, 0.005) 0.001 0.004(0.001, 0.006) 0.002 0.00 0.91 -0.001 0.95 0.00 0.94
Ln baPWV, cm/sec⁑ 0.45(0.010, 0.879) 0.045 0.85(0.346, 1.354) 0.002 0.41 0.22 0.45 0.77 0.39 0.31
Ln LAVI max, ml/ m2
systolic BP, mmHg 0.002(0.000, 0.004) 0.042 0.004(0.001, 0.006) 0.002 0.002 0.26 0.002 0.27 0.002 0.49
diastolic BP, mmHg -0.002(-0.006, 0.001) 0.13 0.000(-0.004, 0.004) 0.84 0.002 0.43 0.002 0.48 0.002 0.39
mean BP, mmHg 0.000(-0.003, 0.003) 0.99 0.002(-0.001, 0.006) 0.22 0.002 0.33 0.002 0.36 0.002 0.34
Pulse pressure, mmHg 0.007(0.004, 0.010) <0.001 0.009(0.006, 0.012) <0.001 0.002 0.35 0.002 0.36 0.002 0.37
Ea, mmHg/ml -0.061(-0.116, -0.005) 0.013 -0.046(-0.103, 0.010) 0.11 0.014 0.72 0.012 0.77 0.009 0.83
SVRI, dyne�m2/s�cm-5 -0.002(-0.006, 0.001) 0.032 -0.004(-0.008, 0.001) 0.14 -0.001 0.67 -0.002 0.58 -0.002 0.53
TAC, ml/mmHg 0.011(-0.114, 0.136) 0.96 -0.050(-0.246, 0.146) 0.61 -0.047 0.69 -0.044 0.71 -0.034 0.78
LVMI, g/ m2 0.008(0.006, 0.009) <0.001 0.007(0.005, 0.010) <0.001 0.001 0.34 0.001 0.29 0.001 0.32
Ln baPWV, cm/sec⁑ 0.088(-0.396, 0.573) 0.72 0.35(0.162, 0.856) 0.17 0.26 0.46 0.42 0.18 0.27 0.30
LAEF, %
systolic BP, mmHg 0.034(-0.047, 0.115) 0.95 -0.16(-0.247, -0.073) <0.001 -0.19 0.002 -0.20 0.001 -0.19 0.002
diastolic BP, mmHg -0.010(-0.109, 0.130) 0.82 -0.13(-0.263, 0.010) 0.070 -0.14 0.15 -0.14 0.13 -0.14 0.14
mean BP, mmHg 0.033(-0.075, 0.140) 0.98 -0.16(-0.285, -0.030) 0.016 -0.19 0.028 -0.20 0.023 -0.19 0.029
Pulse pressure, mmHg 0.065(-0.052, 0.182) 0.73 -0.23(-0.357, -0.108) <0.001 -0.30 0.001 -0.30 0.001 -0.31 0.001
Ea, mmHg/ml -1.38(-3.50, 0.74) 0.39 -2.27(-4.210, -0.330) 0.022 -0.90 0.55 -0.98 0.51 0.88 0.56
SVRI, dyne�m2/s�cm-5 -0.13(-0.252, 0.002) 0.10 -0.16(-0.319, 0.007) 0.006 -0.031 0.77 -0.049 0.64 -0.031 0.77
TAC, ml/mmHg 0.59(-3.540, 6.232) 0.74 5.13(-1.655, 11.84) 0.014 3.75 0.39 3.69 0.39 3.64 0.41
LVMI, g m2 -0.070(-0.138, -0.002) 0.003 -0.11(-0.190, -0.017) 0.020 -0.034 0.56 -0.041 0.47 -0.037 0.52
Ln baPWV, cm/sec⁑ -3.87(-21.39, 13.66) 0.66 -11.1(-31.59, 9.448) 0.28 1.12 0.95 -6.21 0.73 -0.73 0.99
LVEF, %
systolic BP, mmHg -0.032(-0.069, 0.005) 0.091 0.012(-0.027, 0.051) 0.55 0.044 0.12 0.044 0.12 0.049 0.85
diastolic BP, mmHg -0.067(-0.122,-0.012) 0.016 0.011(-0.048, 0.071) 0.71 0.078 0.063 0.078 0.066 0.077 0.065
mean BP, mmHg -0.058(-0.108, -0.009) 0.020 0.008(-0.048, 0.064) 0.78 0.067 0.088 0.066 0.092 0.069 0.074
(Continued)
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aortic length was confirmed in this age-matched cohort (p = 0.049), but with borderline signif-
icance after adjusting for the aortic volume (p = 0.051). Sex differences between LAEF and BPs
remained significant, but not those with other afterload markers. No sex differences between
LA size and afterload were corroborated. Regarding LV systolic function, the sensitivity analy-
ses supported all of the findings in the whole population. Significant sex differences between
LVEF and afterload parameters were found, in which there was an inverse linear association
between LVEF and Ea only in men but not in women, with a significant sex interaction before
and after adjusting for the aortic length (p = 0.018 and 0.017, respectively) and for the aortic
volume (p = 0.010). Similar sex differences were found in the relationship between LVEF and
SVRI before (p = 0.021) and after adjusting for the aorta sizes (aorta length; p = 0.020, aorta
volume; p = 0.008). These finding were also confirmed in the models adjusted for height and
weight (Table 5)
Among the subgroup of patients with baPWV (n = 69, male; 44, female; 25), we observed
similar associations: significant relationship between baPWV and e’ in women but not in men.
However, the interaction was not statistically significant (p = 0.19), presumably due to less sta-
tistical power. In addition, the strongest determinants of the aortic size were BSA for the aortic
length and age for the aortic volume (Table 6).
Discussion
This is the first study which assessed whether the aortic size alters the magnitude of sex differ-
ence between LV diastolic function and afterload. Through a comprehensive hemodynamic
Table 3. (Continued)
Univariable linear regression models Models with interaction for sex difference
Men (n = 307) Women (n = 189) Interaction Interaction
Adjusted for
Aorta length
Interaction
Adjusted for
Aorta volume
β(95% CI) p value β(95% CI) p value β p-value β p-value β p-value
Pulse pressure, mmHg 0.001(-0.050, 0.053) 0.96 0.021(-0.028, 0.070) 0.41 0.022 0.59 0.021 0.60 0.036 0.38
Ea, mmHg/ml -1.77(-2.735, -0.813) <0.001 -0.25(-1.099, 0.604) 0.57 1.53 0.021 1.53 0.021 1.66 0.012
SVRI, dyne�m2/s�cm-5 -0.12(-0.173, -0.058) <0.001 -0.021(-0.092, 0.050) 0.56 0.095 0.048 0.096 0.045 0.11 0.026
TAC, ml/mmHg 2.98(-0.747, 5.209) 0.009 1.02(-1.909, 3.950) 0.69 -1.96 0.31 -1.92 0.32 -2.33 0.23
LVMI, g/ m2 -0.03(-0.062, 0.001) 0.056 -0.013(-0.051, 0.025) 0.51 0.018 0.49 0.016 0.34 0.025 0.35
Ln baPWV, cm/sec⁑ -0.278(-11.95, 6.387) 0.55 1.067(-7.159, 9.293) 0.79 -1.06 0.89 -2.22 0.62 -0.41 0.92
s’,cm/sec
systolic BP, mmHg -0.013(-0.025, -0.001) 0.028 -0.019(-0.030, -0.007) 0.002 -0.006 0.51 -0.006 0.49 -0.006 0.61
diastolic BP, mmHg -0.008(-0.025, 0.010) 0.39 -0.015(-0.033, 0.003) 0.099 -0.008 0.57 -0.008 0.55 -0.008 0.57
mean BP, mmHg -0.014(-0.030, 0.001) 0.076 -0.023(-0.040, -0.006) 0.008 -0.009 0.47 -0.009 0.45 -0.009 0.48
Pulse pressure, mmHg 0.001(-0.050, 0.053) 0.96 0.021(-0.028, 0.070) 0.41 -0.006 0.64 -0.006 0.67 -0.007 0.57
Ea, mmHg/ml -0.52(-0.826, -0.221) 0.001 -0.33(-0.588, -0.078) 0.38 0.191 0.35 0.19 0.36 0.18 0.37
SVRI, dyne�m2/s�cm-5 -0.045(-0.063, -0.027) <0.001 -0.033(-0.054, -0.012) 0.011 0.012 0.42 0.011 0.11 0.010 0.50
TAC, ml/mmHg 1.24(0.546, 1.936) 0.001 1.33(0.462, 2.204) 0.003 0.092 0.88 0.098 0.87 0.11 0.85
LVMI, g/ m2 -0.014(-0.024, -0.004) 0.006 -0.018(-0.029, -0.007) 0.002 -0.004 0.17 -0.005 0.52 -0.004 0.59
Ln baPWV, cm/sec⁑ -0.278(-11.95, 6.387) 0.55 1.067(-7.159, 9.293) 0.79 0.021 0.99 -0.055 0.98 0.021 0.58
e’, end diastolic velocity of the mitral annulus; LAVI max, maximum left atrial volume index; LAEF, left atrial emptying fraction; LVEF, left ventricular ejection fraction;
s’, systolic mitral annular velocity; BP, blood pressure; Ea, arterial elastance; SVRI, systemic vascular resistance index; TAC, total arterial compliance; LVMI, left
ventricular mass index; Ln baPWV, log-transformed brachial ankle pulse wave velocity.
⁑In whole population, baPWV was measured in 69 cases (44 in men, in 25 women). In age matched population, 49 cases (25 in men, 24 in women)
https://doi.org/10.1371/journal.pone.0214907.t003
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evaluation of elderly patients with preserved EF, we found 1) that only weak associations were
found between BSA and the aortic sizes (length and volume) measured with CT; 2) that we
confirmed statistically significant sex differences in the relationships between LV diastolic
function and afterload in our population; 3) that adjusting for the aortic sizes had minimal
effects on the sex dimorphism; 4) that sex differences were independent from the aortic sizes,
more accurate anatomical parameters of the vascular sizes; and 5) that among the afterload
parameters, aggressive BP lowering would be more beneficial in women than in men because
sex difference was more prominent between diastolic function and BPs.
Sex differences between LV diastolic function and afterload
Although male sex is a risk factor for many cardiovascular diseases, women outnumber men
with HFPEF by a 2:1 ratio.[23, 24] Previous studies have shown sex differences between LV
diastolic function and afterload in smaller populations with different perspectives.[8, 19] Shim
et al. reported a sex disparity in the relationship between PP amplification and e0 or E/e0
among 158 age-matched subjects (79 men and 79 women).[8] Coutinho et al. demonstrated a
sex difference in the association between the E/A ratio and afterload (i.e., TAC or aortic
impedance) among 461 non-heart failure participants.[19] Our study corroborated these find-
ings in a larger sample of non-heart failure population with preserved EF in order to avoid the
contaminating effects from reduced EF, where women had slower LV relaxation (e0), higher
Fig 3. Interactions by sex for the associations between ln e0 and afterload in the whole population. The association of the log-transformed e0 against systolic
blood pressure (BP) is illustrated in A, against diastolic BP in B, against mean BP in C, against pulse pressure in D, against Ea in E, against SVRI in F, against
TAC in G, and against LVMI in H. Ea, arterial elastance; LVMI, left ventricular mass index; SVRI, systemic vascular resistance index; TAC, total arterial
compliance.
https://doi.org/10.1371/journal.pone.0214907.g003
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Table 4. Sex specific univariable linear regression analysis and sex differences in associations between afterload and cardiac function in AGE-MATCHED sample.
Univariable linear regression models Models with interaction for sex difference
Men (n = 162) Women (n = 162) Interaction Interaction
Adjusted for
Aorta length
Interaction
Adjusted for
Aorta volume
β(95% CI) p value β(95% CI) p value β p-value β p-value β p-value
Ln e’(average), cm/sec
systolic BP, mmHg -0.002(-0.005, 0.000) 0.052 -0.006(-0.008, -0.004) <0.001 -0.004 0.014 -0.004 0.021 -0.004 0.017
diastolic BP, mmHg -0.003(-0.006, 0.001) 0.14 -0.008(-0.011, -0.005) <0.001 -0.005 0.027 -0.005 0.046 -0.005 0.029
mean BP, mmHg -0.003(-0.007, 0.000) 0.032 -0.009(-0.012, -0.005) <0.001 -0.004 0.022 -0.005 0.035 -0.005 0.025
Pulse pressure, mmHg -0.002(-0.005, 0.001) 0.24 -0.006(-0.010, -0.003) <0.001 -0.004 0.053 -0.004 0.051 -0.004 0.051
Ea, mmHg/ml -0.13(-0.189, -0.078) <0.001 -0.15(-0.196, -0.107) <0.001 -0.018 0.62 -0.018 0.61 -0.013 0.70
SVRI, dyne�m2/s�cm-5 -0.007(-0.010, -0.004) <0.001 -0.010(-0.013, -0.006) <0.001 -0.004 0.14 -0.003 0.19 -0.003 0.19
TAC, ml/mmHg 0.29(0.154, 0.433) <0.001 0.45(0.333, 0.646) <0.001 0.16 0.13 0.17 0.097 0.16 0.12
LVMI, g/ m2 -0.002(-0.004, 0.000) 0.017 -0.004(-0.006, -0.002) <0.001 -0.002 0.25 -0.001 0.65 -0.001 0.39
Ln baPWV, cm/sec⁑ -0.92(-1.738, -0.105) 0.029 -0.35(-1.074, -0.384) 0.34 0.58 0.29 0.60 0.27 0.00 0.25
Ln E/e’(average)
systolic BP, mmHg 0.003(0.000, 0.005) 0.031 0.005(0.003, 0.008) <0.001 0.002 0.19 0.002 0.20 0.002 0.22
diastolic BP, mmHg -0.001(-0.005, 0.003) 0.60 0.005(0.001, 0.008) 0.028 0.006 0.044 0.005 0.049 0.005 0.051
mean BP, mmHg 0.001(-0.002, 0.005) 0.39 0.006(0.003, 0.010) 0.001 0.002 0.061 0.005 0.065 0.005 0.063
Pulse pressure, mmHg 0.006(0.002, 0.009) 0.001 0.007(0.003, 0.010) <0.001 0.001 0.79 0.001 0.78 0.001 0.72
Ea, mmHg/ml 0.046(-0.018, 0.109) 0.16 0.091(0.037, 0.145) 0.001 0.046 0.78 0.045 0.29 0.040 0.35
SVRI, dyne�m2/s�cm-5 0.002(-0.002, 0.006) 0.26 0.005(0.000, 0.010) 0.032 0.003 0.34 0.003 0.37 0.002 0.45
TAC, ml/mmHg -0.15(-0.226, -0.015) 0.015 -0.31(-0.498, -0.127) 0.001 -0.12 0.33 -0.12 0.31 -0.11 0.38
LVMI, g/ m2 0.003(0.001, 0.005) 0.003 0.003(0.001, 0.006) 0.014 0.001 0.99 0.00 0.98 0.001 0.39
Ln baPWV, cm/sec⁑ 0.69(0.045, 1342) 0.037 0.22(0.446, 0.891) 0.50 -0.47 0.31 -0.45 0.34 0.00 0.25
Ln LAVI max, ml/ m2
systolic BP, mmHg 0.003(0.001, 0.005) 0.005 0.004(0.001, 0.006) 0.002 0.00 0.85 0.00 0.86 0.00 0.89
diastolic BP, mmHg -0.002(-0.005, 0.001) 0.21 -0.001(-0.005, 0.003) 0.65 0.004 0.23 0.004 0.24 0.004 0.19
mean BP, mmHg 0.001(-0.002, 0.004) 0.44 0.002(-0.002, 0.005) 0.41 0.00 0.36 0.003 0.37 0.003 0.35
Pulse pressure, mmHg 0.008(0.005, 0.010) <0.001 0.008(0.005, 0.011) <0.001 -0.001 0.59 -0.001 0.59 -0.002 0.55
Ea, mmHg/ml -0.068(-0.121, -0.014) 0.013 -0.055(-0.109, -0.002) 0.044 0.008 0.87 0.007 0.88 0.003 0.94
SVRI, dyne�m2/s�cm-5 -0.003(-0.006, 0.000) 0.092 -0.004(-0.009, 0.000) 0.037 -0.002 0.62 -0.002 0.56 -0.002 0.50
TAC, ml/mmHg 0.011(-0.114, 0.136) 0.86 -0.047(-0.243, 0.148) 0.63 0.081 0.56 0.078 0.57 0.091 0.51
LVMI, g/ m2 0.008(0.006, 0.009) <0.001 0.007(0.005, 0.010) <0.001 0.00 0.76 0.001 0.65 0.001 0.73
Ln baPWV, cm/sec⁑ 0.47(-0.135, 1.080) 0.12 0.48(-0.157, 1.110) 0.13 0.30 0.56 0.34 0.49 0.00 0.56
LAEF, %
systolic BP, mmHg 0.002(-0.072, 0.077) 0.95 -0.16(-0.240, -0.079) <0.001 -0.22 0.002 -0.22 0.002 -0.22 0.002
diastolic BP, mmHg -0.013(-0.125, 0.099) 0.82 -0.11(-0.231, 0.022) 0.11 -0.20 0.058 -0.21 0.048 -0.21 0.053
mean BP, mmHg 0.001(-0.098, 0.101) 0.98 -0.145(-0.266, -0.024) 0.019 -0.22 0.011 -0.26 0.009 -0.26 0.011
Pulse pressure, mmHg 0.019(-0.087, 0.125) 0.73 -0.21(-0.320, -0.104) <0.001 -0.28 0.005 -0.28 0.005 -0.29 0.004
Ea, mmHg/ml -0.86(-2.847, 1.123) 0.39 -0.002(-0.003, 0.000) 0.004 -1.33 0.43 -1.38 0.41 -1.33 0.44
SVRI, dyne�m2/s�cm-5 -0.001(-0.002, 0.000) 0.10 6.24(-0.249, 12.735) 0.018 -0.037 0.76 -0.056 0.64 -0.039 0.75
TAC, ml/mmHg 0.79(-3.781, 5.356) 0.74 -0.067(-0.202, 0.068) 0.059 2.68 0.58 2.50 0.61 2.58 0.60
LVMI, g m2 0.20(0.031, 0.371) 0.021 0.21(-0.042, 0.464) 0.10 0.001 0.99 -0.009 0.88 -0.003 0.96
Ln baPWV, cm/sec⁑ 5.0(-23.25, 33.21) 0.72 -10.4(-35.48, 14.61) 0.40 -14.2 0.60 -16.0 0.54 -0.010 0.54
LVEF, %
systolic BP, mmHg -0.026(-0.077, 0.024) 0.31 0.016(-0.024, 0.055) 0.44 0.042 0.20 0.042 0.20 0.048 0.13
diastolic BP, mmHg -0.056(-0.129, 0.016) 0.13 0.017(-0.044, 0.078) 0.58 0.074 0.13 0.073 0.13 0.075 0.12
mean BP, mmHg -0.050(-0.118, 0.017) 0.14 0.014(-0.044, 0.071) 0.64 0.042 0.15 0.064 0.16 0.067 0.13
Pulse pressure, mmHg -0.002(-0.071, 0.067) 0.95 0.020(-0.036, 0.076) 0.49 0.022 0.62 0.021 0.63 0.037 0.41
(Continued)
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filling pressure (E/e0), and lower LA function (LAEF). This was supported by higher serum
BNP levels in women than in men. Intriguingly, there were discrepancies among these dia-
stolic functional parameters between the sexes. Statistically significant interactions by sex were
detected in functions but not in LA size. This could be due to our cross-sectional study design,
because LA volume reflects chronic LA pressure overload and would be less sensitive to instan-
taneous changes in hemodynamics.[25]
In this study of elderly people with preserved EF, although BPs were similar between the
sexes, women had greater afterload (Ea and TAC) as well as more deteriorated diastolic func-
tion. This finding supports a previous report that advanced age and female sex were associated
with increases in vascular and ventricular stiffness, even in the absence of cardiovascular dis-
eases.[26] Furthermore, we focused on elderly people because aging is an independent risk fac-
tor for both types of HF[27]. However, it is noted that a southwestern European community
study reported that the prevalence of HFPEF increased more rapidly with age than did the
prevalence of HFREF.[6]
Next, there were two intriguing findings on LVEF in this study. A greater LVEF was
observed in women, consistent with a report from the Dallas Heart Study,[28] which also sug-
gested different normal ranges for LVEF. The other finding was that associations between
LVEF and afterload were only significant among men. In other words, there were no relation-
ships between LVEF and afterload markers in women, suggesting that LVEF may not be a sen-
sitive parameter of afterload burden in women. Collectively, a greater impairment in diastolic
function among elderly women with increased afterload may possibly contribute to greater
susceptibility to HFPEF, though further study is warranted.
Table 4. (Continued)
Univariable linear regression models Models with interaction for sex difference
Men (n = 162) Women (n = 162) Interaction Interaction
Adjusted for
Aorta length
Interaction
Adjusted for
Aorta volume
β(95% CI) p value β(95% CI) p value β p-value β p-value β p-value
Ea, mmHg/ml -1.96(-3.12, -0.739) 0.002 -0.18(-1.040, 0.675) 0.68 -1.78 0.018 1.79 0.017 1.92 0.010
SVRI, dyne�m2/s�cm-5 -0.13(-0.205, -0.061) <0.001 -0.012(-0.085, 0.061) 0.75 0.12 0.021 0.12 0.020 0.14 0.008
TAC, ml/mmHg 3.92(0.851, 6.980) 0.013 0.97(-1.976, 3.912) 0.52 -2.95 0.18 -2.94 0.18 -3.21 0.14
LVMI, g/ m2 -0.050(-0.091, -0.009) 0.018 -0.012(-0.050, 0.027) 0.55 0.038 0.19 0.036 0.22 0.049 0.089
Ln baPWV, cm/sec⁑ 4.32(-17.11, 25.74) 0.68 0.24(-10.88, 11.37) 0.96 -4.07 0.72 -4.30 0.71 -0.002 0.78
s’, cm/sec
systolic BP, mmHg -0.012(-0.027, 0.003) 0.11 -0.018(-0.029, -0.006) 0.002 -0.006 0.55 -0.006 0.53 -0.006 0.54
diastolic BP, mmHg -0.007(-0.029, 0.014) 0.51 -0.017(-0.035, 0.000) 0.053 -0.010 0.075 -0.011 0.46 -0.011 0.46
mean BP, mmHg -0.014(-0.034, 0.006) 0.17 -0.024(-0.040, -0.007) 0.005 -0.006 0.47 -0.010 0.44 -0.010 0.46
Pulse pressure, mmHg -0.015(-0.035, 0.005) 0.15 -0.021(-0.037, -0.005) 0.010 -0.006 0.64 -0.006 0.63 -0.007 0.59
Ea, mmHg/ml -0.61(-0.970, -0.240) 0.001 -0.33(-0.576, -0.085) 0.009 0.28 0.21 0.28 0.21 0.26 0.23
SVRI, dyne�m2/s�cm-5 -0.044(-0.065, -0.022) <0.001 -0.034(-0.054, -0.013) 0.001 0.010 0.16 0.009 0.55 0.008 0.62
TAC, ml/mmHg 1.37(0.456, 2.279) 0.004 1.15(0.305, 1.991) 0.008 -0.22 0.73 -0.22 0.73 -0.19 0.77
LVMI, g/ m2 -0.022(-0.034, -0.010) 0.001 -0.014(-0.025, -0.003) 0.016 0.008 0.34 0.007 0.43 0.008 0.36
Ln baPWV, cm/sec⁑ -316(-8.650, 2.329) 0.25 0.39(-1.867, 2.647) 0.72 3.55 0.20 3.41 0.21 0.002 0.22
e’, end diastolic velocity of the mitral annulus; LAVI max, maximum left atrial volume index; LAEF, left atrial emptying fraction; LVEF, left ventricular ejection fraction;
s’, systolic mitral annular velocity; BP, blood pressure; Ea, arterial elastance; SVRI, systemic vascular resistance index; TAC, total arterial compliance; LVMI, left
ventricular mass index; Ln baPWV, log-transformed brachial ankle pulse wave velocity.
⁑In whole population, baPWV was measured in 69 cases (44 in men, in 25 women). In age matched population, 49 cases (25 in men, 24 in women)
https://doi.org/10.1371/journal.pone.0214907.t004
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This was the first study to focus on the aortic length and volume as measured by CT in
order to determine whether there was significant effect modification by sex on the effects of
afterload on LV diastolic function even after adjusting for the disparity in body size by sex.
Previous studies have tested independent associations after adjusting for body surface area
(BSA), based on the assumption that BSA is a reasonable surrogate for aortic length[7, 8]
although little is known about the strength of the association between BSA and aortic volume/
length. Furthermore, BSA is only one of the factors affecting the aortic size.[29, 30] Indeed,
BSA and aorta size had only weak association in both men and women in this study. Thus, we
thought it is more reasonable adjusting for the aorta sizes considering the mechanism underly-
ing the arterial wave reflections and function of buffering pulsatile pressure from the heart.
[31] Because sex difference between LV diastolic function and afterload remained significant
after adjusting for aorta size, the differences in the conduit size did not fully account for the
sex difference in the relationship between afterload and LV relaxation.
Study limitations
Some limitations should be noted for this study. Firstly, this was a retrospective, cross-sectional
study performed in a single tertiary institution and in a population with a single ethnicity. It
therefore may have inherent flaws related to selection bias, spurious observations, and unmea-
sured covariates. Due to the retrospective nature of the data collection, several pieces of
Fig 4. Interactions by sex for the associations between ln e0 and afterload in the age-matched population. The association of the log-transformed e0 against
systolic blood pressure (BP) is illustrated in A, against diastolic BP in B, against mean BP in C, against pulse pressure in D, against Ea in E, against SVRI in F,
against TAC in G, and against LVMI in H. Abbreviations are in Fig 2.
https://doi.org/10.1371/journal.pone.0214907.g004
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Table 5. Sex specific linear regression analysis and sex differences in associations between afterload and cardiac function in WHOLE sample.
Linear regression models Models with interaction for sex difference
Men (n = 307) Women (n = 189) Interaction Interaction
Adjusted for
Aorta length
Interaction
Adjusted for
Aorta volume
β(95% CI) p value β(95% CI) p value β p-value β p-value β p-value
Ln e’(average), cm/sec
systolic BP, mmHg -0.002(-0.003, 0.000) 0.071 -0.006(-0.008, -0.004) <0.001 -0.004 0.001 -0.004 0.002 -0.005 <0.001
diastolic BP, mmHg -0.002(-0.005, 0.001) 0.18 -0.008(-0.011, -0.005) <0.001 -0.007 0.001 -0.006 0.003 -0.007 0.001
mean BP, mmHg -0.002(-0.005, 0.000) 0.072 -0.008(-0.012, -0.005) <0.001 -0.008 <0.001 -0.006 0.001 -0.006 <0.001
Pulse pressure, mmHg -0.001(-0.004, 0.001) 0.24 -0.005(-0.008, -0.002) 0.001 -0.004 0.037 -0.004 0.042 -0.004 0.030
Ea, mmHg/ml -0.089(-0.136, -0.041) <0.001 -0.12(-0.168, -0.072) <0.001 -0.040 0.21 -0.034 0.27 -0.033 0.28
SVRI, dyne�m2/s�cm-5 -0.006(-0.009, -0.006) <0.001 -0.010(-0.014, -0.006) <0.001 -0.004 0.053 -0.004 0.098 -0.004 0.077
TAC, ml/mmHg 0.19(0.081, 0.290) 0.001 0.34(0.171, 0.512) <0.001 0.17 0.059 0.15 0.082 0.15 0.086
LVMI, g/ m2 -0.002(-0.004, -0.001) 0.002 -0.004(-0.006, -0.002) <0.001 -0.002 0.14 -0.001 0.40 -0.002 0.18
Ln baPWV, cm/sec⁑ -0.56(-1.172, 0.053) 0.072 -0.39(-1.158, 0.375) 0.29 -0.054 0.90 0.096 0.82 0.026 0.95
Ln E/e’(average), cm/sec
systolic BP, mmHg 0.002(0.004, 0.943) <0.001 0.005(0.003, 0.008) <0.001 0.003 0.037 0.003 0.048 0.005 <0.001
diastolic BP, mmHg 0.00(-0.003, 0.003) 0.82 0.004(0.008, 0.860) <0.001 0.004 0.093 0.004 0.13 0.004 0.086
mean BP, mmHg 0.001(-0.002, 0.004) 0.47 0.007(0.003, 0.011) 0.001 0.006 0.003 0.005 0.032 0.005 0.024
Pulse pressure, mmHg 0.004(0.001, 0.007) 0.007 0.007(0.003, 0.011) <0.001 0.003 0.13 0.003 0.14 0.003 0.13
Ea, mmHg/ml 0.006(-0.048, 0.061) 0.82 0.058(-0.003, 0.120) 0.063 0.052 0.17 0.047 0.21 0.047 0.21
SVRI, dyne�m2/s�cm-5 0.002(-0.001, 0.004) 0.20 0.005(0.011, 0.766) <0.001 0.003 0.34 0.002 0.47 0.002 0.41
TAC, ml/mmHg -0.072(-0.192, 0.048) 0.24 -0.20(-0.412, 0.017) 0.071 -0.13 0.24 -0.067 0.27 0.11 0.30
LVMI, g/ m2 0.003(0.002, 0.005) <0.001 0.003(0.001, 0.006) 0.009 0.003 0.98 0.00 0.86 0.00 0.93
Ln baPWV, cm/sec⁑ 0.59(0.016, 1.163) 0.044 0.94(0.259, 1.618) 0.010 0.38 0.29 0.48 0.20 0.36 0.35
Ln LAVI max, ml/ m2
systolic BP, mmHg 0.004(0.001, 0.006) 0.002 0.005(0.002, 0.007) 0.001 0.001 0.87 0.001 0.42 0.004 <0.001
diastolic BP, mmHg 0.00(-0.003, 0.003) 0.92 0.001(-0.004, 0.005) 0.79 0.001 0.57 0.001 0.65 0.002 0.49
mean BP, mmHg 0.002(-0.001, 0.005) 0.18 0.003(-0.001, 0.007) 0.088 0.004 0.072 0.002 0.50 0.002 0.43
Pulse pressure, mmHg 0.007(0.004, 0.010) <0.001 0.009(0.005, 0.012) <0.001 0.002 0.32 0.002 0.34 0.002 0.37
Ea, mmHg/ml -0.063(-0.121, -0.004) 0.036 -0.067(-0.127, -0.007) 0.028 0.008 0.84 0.004 0.92 -0.001 0.99
SVRI, dyne�m2/s�cm-5 0.001(-0.002, 0.005) 0.53 -0.002(-0.008, 0.003) 0.38 -0.001 0.61 -0.002 0.48 -0.002 0.44
TAC, ml/mmHg 0.006(-0.125, 0.138) 0.92 0.044(-0.167, 0.256) 0.68 0.016 0.89 0.025 0.83 0.042 0.71
LVMI, g/ m2 0.007(0.005, 0.009) <0.001 0.009(0.007, 0.011) <0.001 0.002 0.19 0.002 0.20 0.002 0.19
Ln baPWV, cm/sec⁑ 0.023(-0.601, 0.646) 0.94 0.38(-0.254, 1.005) 0.22 0.18 0.64 0.35 0.36 0.19 0.61
LAEF, %
systolic BP, mmHg 0,.029(-0.059, 0.117) 0.52 -0.16(-0.249, -0.062) 0.001 0.001 0.001 -0.21 0.001 -0.18 0.001
diastolic BP, mmHg -0.021(-0.152, 0.109) 0.75 -0.10(-0.250, 0.046) 0.18 -0.16 0.092 -0.17 0.082 -0.16 0.093
mean BP, mmHg 0.009(-0.110, 0.128) 0.89 -0.14(-0.280, 0.000) 0.050 -0.20 0.018 -0.22 0.013 -0.22 0.016
Pulse pressure, mmHg 0.077(-0.042, 0.197) 0.20 -0.23(-0.362, -0.104) <0.001 -0.31 0.001 -0.31 0.001 -0.32 <0.001
Ea, mmHg/ml -1.21(-3.541, 1.124) 0.31 -2.15(-4.267, -0.030) 0.047 0.89 0.56 -0.97 0.52 0.82 0.59
SVRI, dyne�m2/s�cm-5 -0.21(-0.346, -0.069) 0.004 -0.15(-0.336, 0.038) 0.12 -0.042 0.70 -0.058 0.59 -0.039 0.72
TAC, ml/mmHg 0.13(-5.028, 5.281) 0.96 4.56(-2.899, 12.01) 0.23 3.27 0.45 3.19 0.46 2.96 0.50
LVMI, g m2 -0.072(-0.141, -0.003) 0.040 -0.11(-0.202, -0.021) 0.016 -0.048 0.40 -0.53 0.36 -0.053 0.36
Ln baPWV, cm/sec⁑ 6.73(-23.06, 36.51) 0.65 -9.40(-44.77, 25.96) 0.58 -7.63 0.71 -17.8 0.38 -10.20 0.62
LVEF, %
systolic BP, mmHg -0.035(-0.076, 0.006) 0.091 -0.005(-0.046, 0.036) 0.81 0.048 0.093 0.048 0.095 0.014 0.11
diastolic BP, mmHg -0.060(-0.121, 0.000) 0.051 -0.014(-0.078, 0.049) 0.66 0.076 0.078 0.076 0.079 0.075 0.080
mean BP, mmHg -0.059(-0.114, -0.004) 0.035 -0.020(-0.080, 0.040) 0.51 -0.004 0.026 0.066 0.10 0.068 0.085
(Continued)
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information were not available, including history of physical exercise and precise reason/s for
BNP measurements. Thus, further prospective, multicenter and multi-ethnicity studies are
warranted. Secondly, we calculated hemodynamic parameters with BP measured at a periph-
eral artery, where these parameters might be different from true central hemodynamics.[32,
33] The lack of a central hemodynamic data might make these results linked to a high variabil-
ity. However, sex differences were the most frequently found in BPs. Thirdly, we used the aor-
tic sizes as vascular surrogate of the body size related reflected wave, but we did not measure
reflected wave itself. Therefore, we couldn’t elucidate directly that gender difference was asso-
ciated with reflected wave. However, we observed similar association between e’ and baPWV,
Table 5. (Continued)
Linear regression models Models with interaction for sex difference
Men (n = 307) Women (n = 189) Interaction Interaction
Adjusted for
Aorta length
Interaction
Adjusted for
Aorta volume
β(95% CI) p value β(95% CI) p value β p-value β p-value β p-value
Pulse pressure, mmHg -0.017(-0.072, 0.039) 0.56 0.004(-0.053, 0.062) 0.88 -0.005 0.69 0.031 0.44 0.042 0.31
Ea, mmHg/ml -1.70(-2.768, -0.629) 0.002 -0.61(-1.519, 0.302) 0.19 1.53 0.024 1.54 0.024 1.65 0.014
SVRI, dyne�m2/s�cm-5 -0.11(-0.172, -0.043) 0.001 -0.070(-0.150, 0.009) 0.084 0.086 0.074 0.088 0.071 0.097 0.045
TAC, ml/mmHg 2.94(0.568, 5.319) 0.015 2.34(-0.827, 5.514) 0.15 -1.71 0.38 -1.66 0.39 -2.96 0.28
LVMI, g/ m2 -0.042(-0.074, -0.010) 0.010 -0.019(-0.058, 0.020) 0.33 0.018 0.48 0.016 0.53 0.023 0.37
Ln baPWV, cm/sec⁑ 2.39(-11.80, 16.58) 0.73 -2.28(-12.79, 8.229) 0.65 -6.53 0.43 -8.31 0.33 -6.38 0.46
s’(average), cm/sec
systolic BP, mmHg -0.007(-0.020, 0.005) 0.24 -0.017(-0.029, -0.005) 0.006 -0.009 0.30 -0.009 0.30 -0.016 0.033
diastolic BP, mmHg 0.001(-0.017, 0.020) 0.88 -0.017(-0.035, 0.002) 0.073 -0.017 0.19 -0.017 0.20 -0.017 0.19
mean BP, mmHg -0.006(-0.023, 0.011) 0.50 -0.023(-0.040, -0.005) 0.011 -0.021 0.059 -0.016 0.20 -0.015 0.20
Pulse pressure, mmHg -0.014(-0.031, 0.002) 0.094 -0.019(-0.035, -0.002) 0.029 -0.005 0.69 -0.005 0.70 -0.005 0.66
Ea, mmHg/ml -0.25(-0.578, 0.080) 0.14 -0.21(-0.475, 0.061) 0.13 0.11 0.61 0.11 0.59 0.11 0.60
SVRI, dyne�m2/s�cm-5 -0.041(-0.060, -0.022) <0.001 -0.033(-0.056, -0.010) 0.005 0.010 0.46 0.011 0.46 0.010 0.51
TAC, ml/mmHg 0.67(-0.057, 1.391) 0.071 0.77(-0.167, 1.697) 0.11 -0.067 0.91 -0.073 0.90 -0.076 0.90
LVMI, g/ m2 -0.013(-0.022, -0.003) 0.011 -0.014(-0.026, -0.003) 0.013 -0.004 0.63 -0.004 0.61 -0.004 0.64
Ln baPWV, cm/sec⁑ -0.958(-4.543, 2.628) 0.59 -1.527(-4.452, 1.399) 0.28 0.74 0.72 -0.78 0.72 -0.69 0.75
Above multivariable models were adjusted for height, weight, DM, IHD, smoking, Hb and Cr.
e’, end diastolic velocity of the mitral annulus; LAVI max, maximum left atrial volume index; LAEF, left atrial emptying fraction; LVEF, left ventricular ejection fraction;
s’, systolic mitral annular velocity; BP, blood pressure; Ea, arterial elastance; SVRI, systemic vascular resistance index; TAC, total arterial compliance; LVMI, left
ventricular mass index; Ln baPWV, log-transformed brachial ankle pulse wave velocity.
⁑In whole population, baPWV was measured in 69 cases (44 in men, in 25 women). In age matched population, 49 cases (25 in men, 24 in women)
https://doi.org/10.1371/journal.pone.0214907.t005
Table 6. The association with aorta size (Aortic length and volume).
Aortic Length(R2 = 0.50) Aortic Volume(R2 = 0.44)
Age, years 0.21(0.137, 0.280) <0.001 2.49(1.524, 3.460) <0.001
Body surface area, m2 12.0(7.892, 16.07) <0.001 146.3(204.7, 204.7) <0.001
Ln E/e’(average) -3.24(-5.888, -0.588) 0.017 - -
Diabetes - - -21.7(-43.05, -0.445) 0.045
Above multivariable regression analysis were adjusted for age, body size(height, weight, BSA and BMI), coronary risk factor(HT,DM,DL,IHD), afterload parameters
(systolic BP, diastolic BP, mean BP, Pulse Pressure, Ea, SVRI, TAC, LVMI and baPWV) and parameters of cardiac function(Ln e’, Ln E/e’, Ln LAVI, LAEF, LVEF and
s’).
https://doi.org/10.1371/journal.pone.0214907.t006
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where only women had a significant association but this was not seen in men although the
interaction was not significant due to smaller sample size (n = 69) and less statistical power.
Also, because we excluded patients with atrial fibrillation, our results cannot be readily applica-
ble to those patients. In addition, although our patients’ body sizes were normal for Asians,
our population had a smaller overall body size (mean body mass index, 22.4± 3.8kg/m2) than
that in Western populations.[19, 34] Nevertheless, our findings on the relationship between
afterload and diastolic function were generally similar to those reported in past studies using
patients with larger body sizes.[19, 34] Furthermore, the population of this study were not nor-
mal but aged and diseased samples, who had clinical indications for taking CT and echocardi-
ography. They might not reflect the normal physiology; however, this means they were at
Stage A or B HF patients, which would be a reasonable target to be investigated because of the
risk of subsequent obvert HF. Finally, half of the CT images were performed without contrast,
which may limit the accuracy of the aortic volume assessment, but the effect should be mini-
mal on the aortic length, where most of the findings were consistent between the volume and
length. Despite these limitations, this is the first report to show significant sex differences
between diastolic function and afterload before and after adjusting for the aortic sizes.
Conclusions
Significant sex differences in the relationships between LV diastolic functions and afterload
were confirmed in elderly patients with preserved ejection fraction. Women had worse LV
relaxation compared to those in men with the same degree of afterload, before and after adjust-
ing for the aortic sizes.
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